Departmental news
Plastisphere and polymer-degrading bacteria, in Guardian
Former PhD student interviewed in Guardian about her work at UoW discovering bacteria which can degrade 'plastics'
Cancer research EUTOPIA PhD Student joins Dr Ahmed Eissa
Congratulations go to Dr Ahmed Eissa who has won a grant to host a EUTOPIA PhD student for the project ‘Bone marrow niche – lung cancer crosstalk: gossip or fatal choice of words?’
BonLab designs autonomous electricity-free "icy road" sign
We set out to develop a prototype for “icy road” warning signs which was able to operate autonomously without the use of electricity...
Discovery of minimalistic cyclic ice binding peptides
The Gibson and Sosso groups have collaborated with partners in Switzerland to use phage display to discover small antifreeze peptides. Read more
Exploring Energy Storage for a Greener Future
In November 2018, the Monash Warwick Alliance funded Chemists to develop and identify cost-effective, highly active, selective and stable catalysts. Check their progress...
Polymer Nanoparticles to Control Ice Growth
The GibsonGroup, in collaboration with Dr Tom Whale, have published in the Journal of the American Chemical Society, showing that polymer nanoparticles can inhibit ice growth. Read more...
Funding granted for cleaner, greener chemicals
Researchers at the Universities of Warwick and Nottingham have received EPSRC funding to launch a ground-breaking research programme for global specialist chemical manufacturer, Lubrizol.
Warwick Spin-Out, CryoLogyx, partners with investors
The University of Warwick spin-out company, CryoLogyx, has received a further investment from Oxford Technology Management and private investors, alongside £300k from InnovateUK.
Solving the puzzle of polymer-ice binding for cryopreservation
When biological material is frozen, cryoprotectants are used to prevent ice damage. How do newly emerging polymeric cryoprotectants control ice formation and growth during freezing?
New company, CryoLogyx, is spun out from the Department
A new biotechnology company, CryoLogyx, has been spun-out from the department, supported from a grant from InnovateUK. Cryologyx will be led by Dr Tom Congdon (A UoW UG and PG alumus) and will exploit technology developed by the GibsonGroup. Cryologyx will use innovative macromolecular (polymeric) cryoprotectants to protect biological samples, including cells used in therapy, diagnostics and drug discovery.
Read the news story here and more details will be released soon.